John Lawson, MD
Allergy & Immunology · Northbrook, ILNPI 1689864357
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 387 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations.
Across 387 payments — averaging $16.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$996
- Sanofi$287
- CSL Behring$187
- Teva Pharmaceuticals USA, Inc.$184
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,29697%
- Education$1763%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 122 | $1,476 |
| AstraZeneca | 83 | $1,463 |
| Regeneron Healthcare Solutions, Inc. | 43 | $996 |
| Sanofi | 14 | $287 |
| CSL Behring | 10 | $187 |
| Teva Pharmaceuticals USA, Inc. | 13 | $184 |
| Novartis | 9 | $181 |
| Genentech USA, Inc. | 10 | $178 |
| Optinose US, Inc. | 10 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $134 |
| Amgen | 8 | $130 |
| Pfizer | 7 | $110 |
| Sanofi-aventis U.S. LLC | 3 | $108 |
| Hospira, Inc. | 5 | $100 |
| Biocryst US Sales Co., LLC | 6 | $92 |
| Octapharma USA, Inc. | 2 | $86 |
| Covis Pharma GmbH | 5 | $82 |
| Shire North American Group Inc | 3 | $75 |
| Grifols USA, LLC | 3 | $58 |
| Boehringer Ingelheim | 3 | $48 |
| Alk-abello, Inc | 3 | $47 |
| Kedrion Biopharma, Inc. | 2 | $41 |
| Greer Laboratories, Inc. | 2 | $40 |
| Galderma Laboratories, L.p. | 2 | $39 |
| Cycle Pharmaceuticals Inc | 2 | $31 |
| Pharming Healthcare, Inc. | 1 | $24 |
| Kaleo, Inc. | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $18 |
| Organon | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Circassia Inc. | 1 | $12 |
| Merck | 1 | $11 |
| Biocryst Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$6,472 in reported general payments places this provider in the 65th percentile of 161 allergy & immunology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CutaquigImmun Glob G(Igg)-Hipp/Maltose | 11 | $90,938 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 42 | $52,222 |
| Breo ElliptaFluticasone/Vilanterol | 31 | $26,825 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,028 |
| Arnuity ElliptaFluticasone Furoate | 30 | $8,952 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $6,561 |
| Qvar RedihalerBeclomethasone Dipropionate | 24 | $6,551 |
| Ipratropium Bromide | 115 | $3,182 |
| Epinephrine | 18 | $2,969 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $1,833 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 55 | $1,510 |
| Azelastine Hcl | 56 | $1,221 |
| Mometasone Furoate | 14 | $753 |
| Montelukast Sodium | 72 | $609 |
| Fluticasone Propionate | 36 | $585 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Octapharma USA, Inc.Cutaquig | $86 | $90,93811 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $1,476 | $87,999103 claims |
| AstraZenecaBreztri Aerosphere | $1,463 | $9,02815 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $184 | $6,55124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 161 allergy & immunology providers in Illinois.
Other allergy & immunology in Northbrook
- Dareen SiriNormal$1.5M
- Priya BansalSaint Charles$1.3M
- Anju PetersChicago$563K
- Giselle MosnaimChicago$331K
- Patrick WinShiloh$258K
- Amanda SalihChicago$160K
- Rebecca HoffmanWilmette$160K
- Juanita MoraChicago$147K
- Sonali MajmudarAlgonquin$136K
- Zachary RubinElmhurst$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.